TF and diabetes mellitus: Although it is important to elucidate the mechanisms that underline the increase in β-cells induced by the R-Tf-D-LP4 peptide treatment in this STZ/HFD-32 fed model, the current reduction of blood glucose levels means that the R-Tf-D-LP4 peptide may represent a potential treatment for diabetes.